Your browser doesn't support javascript.
loading
A structural biology community assessment of AlphaFold2 applications.
Akdel, Mehmet; Pires, Douglas E V; Pardo, Eduard Porta; Jänes, Jürgen; Zalevsky, Arthur O; Mészáros, Bálint; Bryant, Patrick; Good, Lydia L; Laskowski, Roman A; Pozzati, Gabriele; Shenoy, Aditi; Zhu, Wensi; Kundrotas, Petras; Serra, Victoria Ruiz; Rodrigues, Carlos H M; Dunham, Alistair S; Burke, David; Borkakoti, Neera; Velankar, Sameer; Frost, Adam; Basquin, Jérôme; Lindorff-Larsen, Kresten; Bateman, Alex; Kajava, Andrey V; Valencia, Alfonso; Ovchinnikov, Sergey; Durairaj, Janani; Ascher, David B; Thornton, Janet M; Davey, Norman E; Stein, Amelie; Elofsson, Arne; Croll, Tristan I; Beltrao, Pedro.
Afiliação
  • Akdel M; Bioinformatics Group, Department of Plant Sciences, Wageningen University and Research, Wageningen, the Netherlands.
  • Pires DEV; School of Computing and Information Systems, University of Melbourne, Melbourne, Victoria, Australia.
  • Pardo EP; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Spain.
  • Jänes J; Barcelona Supercomputing Center (BSC), Barcelona, Spain.
  • Zalevsky AO; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK.
  • Mészáros B; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russian Federation.
  • Bryant P; European Molecular Biology Laboratory, Heidelberg, Germany.
  • Good LL; Dep of Biochemistry and Biophysics and Science for Life Laboratory, Solna, Sweden.
  • Laskowski RA; Linderstrøm-Lang Centre for Protein Science, Department of Biology, University of Copenhagen, Copenhagen, Denmark.
  • Pozzati G; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK.
  • Shenoy A; Dep of Biochemistry and Biophysics and Science for Life Laboratory, Solna, Sweden.
  • Zhu W; Dep of Biochemistry and Biophysics and Science for Life Laboratory, Solna, Sweden.
  • Kundrotas P; Dep of Biochemistry and Biophysics and Science for Life Laboratory, Solna, Sweden.
  • Serra VR; Dep of Biochemistry and Biophysics and Science for Life Laboratory, Solna, Sweden.
  • Rodrigues CHM; Barcelona Supercomputing Center (BSC), Barcelona, Spain.
  • Dunham AS; School of Computing and Information Systems, University of Melbourne, Melbourne, Victoria, Australia.
  • Burke D; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK.
  • Borkakoti N; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK.
  • Velankar S; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK.
  • Frost A; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK.
  • Basquin J; Department of Biochemistry and Biophysics University of California, San Francisco, CA, USA.
  • Lindorff-Larsen K; Department of Structural Cell Biology, Max Planck Institute of Biochemistry, Martinsried, Germany.
  • Bateman A; Linderstrøm-Lang Centre for Protein Science, Department of Biology, University of Copenhagen, Copenhagen, Denmark.
  • Kajava AV; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK.
  • Valencia A; Université de Montpellier, Centre de Recherche en Biologie Cellulaire de Montpellier (CRBM) CNRS, Montpellier, France.
  • Ovchinnikov S; Barcelona Supercomputing Center (BSC), Barcelona, Spain. alfonso.valencia@bsc.es.
  • Durairaj J; Faculty of Arts and Sciences, Division of Science, Harvard University, Cambridge, MA, USA. so@fas.harvard.edu.
  • Ascher DB; Biozentrum, University of Basel, Basel, Switzerland. janani.durairaj@gmail.com.
  • Thornton JM; School of Chemistry and Molecular Biology, University of Queensland, Brisbane, Queensland, Australia. d.ascher@uq.edu.au.
  • Davey NE; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK. thornton@ebi.ac.uk.
  • Stein A; Institute of Cancer Research, London, UK. norman.davey@icr.ac.uk.
  • Elofsson A; Linderstrøm-Lang Centre for Protein Science, Department of Biology, University of Copenhagen, Copenhagen, Denmark. amelie.stein@bio.ku.dk.
  • Croll TI; Dep of Biochemistry and Biophysics and Science for Life Laboratory, Solna, Sweden. arne@bioinfo.se.
  • Beltrao P; Cambridge Institute for Medical Research, Department of Haematology, The University of Cambridge, Cambridge, UK. tic20@cam.ac.uk.
Nat Struct Mol Biol ; 29(11): 1056-1067, 2022 11.
Article em En | MEDLINE | ID: mdl-36344848
Most proteins fold into 3D structures that determine how they function and orchestrate the biological processes of the cell. Recent developments in computational methods for protein structure predictions have reached the accuracy of experimentally determined models. Although this has been independently verified, the implementation of these methods across structural-biology applications remains to be tested. Here, we evaluate the use of AlphaFold2 (AF2) predictions in the study of characteristic structural elements; the impact of missense variants; function and ligand binding site predictions; modeling of interactions; and modeling of experimental structural data. For 11 proteomes, an average of 25% additional residues can be confidently modeled when compared with homology modeling, identifying structural features rarely seen in the Protein Data Bank. AF2-based predictions of protein disorder and complexes surpass dedicated tools, and AF2 models can be used across diverse applications equally well compared with experimentally determined structures, when the confidence metrics are critically considered. In summary, we find that these advances are likely to have a transformative impact in structural biology and broader life-science research.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biologia Computacional / Furilfuramida Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biologia Computacional / Furilfuramida Idioma: En Ano de publicação: 2022 Tipo de documento: Article